Cyclosporine a pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy

Pharmacological Research

Volumn 40, Issue 6, 1999, Pages 483-486

  Baraldo, M ^a   Ferraccioli, G ^a   Pea, F ^a   Gremese, E ^a   Furlanut, M ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Cyclosporine; Methotrexate; Pharmacokinetics; Rheumatoid arthritis

Indexed keywords

CYCLOSPORIN A; FOLIC ACID ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MONOCLONAL ANTIBODY;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0032763097     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1999.0539     Document Type: Article

References (15)

1. Yocum D. Immunological actions of cyclosporine A in rheumatoid arthritis. Br J Rheumatol. 1993;38-41.
2. Yocum D E. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. Br J Rheumatol. 1996;19-23.
3. Alarcon G S, Tracy I C, Blackburn WD Jr I C. Methotrexate in rheumatoid arthritis. Arthritis Rheum. 32:1989;671-676.
4. Irschik E, Tilg H, Niederwieser D, Gastl G, Huber C, Margreiter R. Cyclosporin blood levels do correlate with clinical complications [letter]. Lancet. 2:1984;692-693.
5. Arnett F C, Edworthy S M, Bloch D A, Mc Shane D J, Fries J F, Cooper N S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1988;315-324.
6. Moyer T P. Evaluation of Abbott Tdx monoclonal assay for monitoring cyclosporine in whole blood. Clin Chem. 37:1991;1120-1121.
7. Ferraccioli G F, Bartoli E. Xenobiotics or biological response modifiers? Methotrexate remains the anchor drug for rheumatoid arthritis. Clin Exp Rheumatol. 16:1998;662-666.
8. Kruger K, Schattenkirchner M. Comparison of cyclosporine A and azathioprine in the treatment of rheumatoid arthritis - results of a double-blind multicentre study. Clin Rheumatol. 13:1994;248-255.
9. Arthritis Rheum. 5:1994;637-643.
10. Br J Rheumatol. 18:1991;815-820.
11. Pasero G, Priolo F, Marubini E, Fantini F, Ferraccioli G F, Magarò M. Slow progression of joint damage in early rheumatoid arthritis treated with CsA. Arthritis Rheum. 39:1996;1006-1015.
12. Tugwell P, Pincus T, Yocum D, Stein M, Gluck O, Kraag G et al O. Co mbination therapy with cyclosporine A and methotrexate in severe rheumatoid arthritis. N Engl J Med. 333:1995;137-141.
13. Mills P M, Sturrock R D. Clinical associations between arthritis and live r disease. Ann Rheum Dis. 41:1982;295-307.
14. Stein C M, Pincus T, Yocum D, Tugwell P, Wells G, Oscar G. Combination treatment of sever rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks. Arthritis Rheum. 40:1997;1843-1850.
15. Stein C M, Brooks R H, Pincus T. Effect of combination therapy with cyclosporine and methotrexate on liver function test results in rheumatoid arthritis. Arthritis Rheum. 40:1997;1721-1723.